FindTrial
Sign In

Evaluation of Topical Tranexamic Acid Use in Knee Periprosthetic Joint Infection

Evaluation of Topical Tranexamic Acid Use in Knee Periprosthetic Joint Infection

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011672
Enrollment
Unknown
Registered
2017-06-15
Start date
2016-01-01
Completion date
Unknown
Last updated
2017-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TKA infection

Interventions

A:topical +IV
B:intravenous application

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: patients diognosed as knee Periprosthetic Joint Infection

Exclusion criteria

Exclusion criteria: age >80 yrs,severe complictions, allergic to TXA

Design outcomes

Primary

MeasureTime frame
haemoglobin level;Blood loss;Hct;Transfusion;ESR, CRP, IL-6;ROM; deep vein thrombosis ;cost;sweeling;nausea and vomiting;drainage;length of hospital stay;pain;reoperation;survivorship;—

Countries

China

Contacts

Public ContactZhou Zongke

West China Hospital, Sichuan University

zongke@126.com+86 18980601028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026